Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...

As a mom to a child withhemophilia, stepping away from sports seemed to be the only way to keep him protected from a life-threatening bleed.

A 28-year-old woman from Gujarat, diagnosed with one of the rarest bleeding disorders in the world, has successfully delivered a healthy baby at a Navi Mumbai hospital, following a high-risk pregnancy ...

Early diagnosis allows for timely preventive treatment and reduces the need for intensive factor replacement therapy in ...

Patients with comorbid autoimmune bullous disease and acquired hemophilia A who were of older age were significantly associated with mortality.

Novo Nordisk today announced that new hemophilia data will be presented at the upcoming International Society on Thrombosis ...

Roughly 55 people on Guam are diagnosed with a bleeding disorder, but as the National Bleeding Disorder Foundation stressed, ...

The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.

The Hemophilia B treatment landscape is entering a new era, marked by disruptive innovation, curative potential, and renewed global attention. Once viewed as a lifelong burden requiring constant ...

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are currently difficult or impossible to treat—for example, aggressive forms of ...

Hemophilia A and B coagulation defects, which are caused by deficiencies of Factor VIII and Factor IX, respectively, can be bypassed by administration of recombinant Factor VIIa. However, the ...